Categories
Nevin Manimala Statistics

Developing and Validating Machine Learning-Driven Risk Indices to Predict Patient Dropout During Referral, Evaluation, and Waitlisting for Kidney Transplant

Clin Transplant. 2025 Sep;39(9):e70325. doi: 10.1111/ctr.70325.

ABSTRACT

BACKGROUND: Transplant is the optimal treatment for kidney failure; however, disparities in access persist. We developed and validated risk indices to predict early dropout at key stages of the transplant-seeking process not captured in national registries.

METHODS: We included patients referred for kidney transplant at Houston Methodist Hospital between June 2016, and November 2023. We collected demographic, clinical, patient- and contextual-level socioeconomic variables from electronic health records and publicly available census data. We used machine learning (ML) models to predict the characteristics of patients at higher risk of dropping out: (1) at referral (before starting evaluation), (2) in the process of evaluation (before waitlisting), and (3) during waitlisting (before receiving a transplant). Model performance was evaluated using AUROC.

RESULTS: Of 4133 referred patients, 46% did not attend their first transplant evaluation visit. Of 2414 patients who were medically eligible for transplant and started evaluation, 54% did not become waitlisted. Of 2457 waitlisted patients, 31% became inactive on the waitlist. Higher risk patients were consistently older, obese, and socioeconomically disadvantaged, with stage-specific differences: social factors-such as being single, unemployed, less educated, and living in high-deprivation areas-and African American race dominated at referral (AUROC 0.79); clinical comorbidities and both African American and Hispanic ethnicity were prominent at evaluation (AUROC 0.71); and Hispanic ethnicity, smoking, and digital exclusion were key drivers at waitlisting (AUROC 0.76).

CONCLUSION: ML models effectively identified dropout risk at referral, evaluation, and waitlisting, enabling early identification of at-risk patients. Targeted interventions could reduce disparities, improve evaluation completion, and increase transplant access.

PMID:40971151 | DOI:10.1111/ctr.70325

Categories
Nevin Manimala Statistics

Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry

Am J Clin Dermatol. 2025 Sep 19. doi: 10.1007/s40257-025-00962-8. Online ahead of print.

ABSTRACT

BACKGROUND: Atopic dermatitis (AD), a chronic systemic disease, can cause intense skin itching and negatively impact sleep, mood, and quality of life (QoL) for patients and families.

METHODS: PEDISTAD is an ongoing, 10-year, observational registry describing disease characteristics, atopic comorbidities, and treatment patterns in pediatric patients (aged <12 years at enrollment) with moderate-to-severe AD. This 3-year interim analysis evaluates clinician-reported and caregiver-reported/patient-reported outcomes (Eczema Area and Severity Index [EASI], percent body surface area affected, worst itching/scratching, Children’s Dermatology Life Quality Index, and Dermatitis Family Impact) in children treated with dupilumab, methotrexate, and/or cyclosporine. Outcomes were assessed as change from therapy start to last observation (either data cutoff date or treatment discontinuation).

RESULTS: Mean (±SE) EASI scores at the time of the last 3-year interim observation were consistent with mild disease in the dupilumab cohort and moderate disease in the methotrexate and cyclosporine cohorts. Improvements in pruritus were numerically greater in the dupilumab cohort relative to the methotrexate and cyclosporine cohorts, while improvements in QoL were similar in the dupilumab and methotrexate cohorts, with no significant change in the cyclosporine cohort. Rates of AD exacerbation were numerically lower with dupilumab treatment relative to methotrexate treatment which were numerically lower than cyclosporine treatment. Dupilumab discontinuation rates were numerically lower relative to methotrexate which were numerically lower than cyclosporine.

CONCLUSIONS: This PEDISTAD 3-year interim analysis of dupilumab, methotrexate, and cyclosporine treatment in children with AD demonstrates numerically greater improvements in AD signs, symptoms and QoL with dupilumab treatment relative to methotrexate and cyclosporine [Video abstract and graphical abstract available].

CLINICAL TRIAL REGISTRATION: NCT03687359. Supplementary file1 (MP4 58163 KB).

PMID:40971133 | DOI:10.1007/s40257-025-00962-8

Categories
Nevin Manimala Statistics

Do all superheroes wear capes? A case-control study of the highest grossing superhero movies

Ir J Med Sci. 2025 Sep 19. doi: 10.1007/s11845-025-04080-6. Online ahead of print.

ABSTRACT

OBJECTIVES: The main goal of this study was to determine the frequency of cape use among superheroes and predictors of superhero status.

DESIGN: Observational case-control study where superheroes were considered cases and villains/neutral characters controls.

SETTING: Top 25 highest grossing superhero movies.

PARTICIPANTS: Main characters in superhero movies classified as superheroes and villains through a multi-tier systems including videographic review and information collected in a superhero community database.

MAIN OUTCOME MEASURES: Frequency of different attributes between superheroes/villains (e.g., cape wearing), correlation of attributes and univariate and multivariable adjusted models of attributes associated with a superhero status.

RESULTS: There were 97 observations of 68 characters over 25 movies from three studios. There were 61 observations of superheroes and 36 villains and neutrals. Just 16% of superheroes wore capes, while 11% of non-superheroes did so. The majority (67%) of superheroes were humans, while among non-superheroes were 56%. Almost all superheroes had an altruistic mission (98%), while this attribute was present in just 19% of non-superheroes.

CONCLUSIONS: In a sample of characters from the highest grossing superhero movies, most superheroes did not wear a cape. The strongest predictor for a superhero status was having an altruistic mission.

PMID:40971124 | DOI:10.1007/s11845-025-04080-6

Categories
Nevin Manimala Statistics

Surgeon-guided transversalis fascia plane block vs. trocar site wound infiltration in pediatric laparoscopic appendectomy

Ir J Med Sci. 2025 Sep 19. doi: 10.1007/s11845-025-04088-y. Online ahead of print.

ABSTRACT

BACKGROUND: Postoperative pain remains a significant concern in pediatric patients undergoing laparoscopic appendectomy. The transversalis fascia plane block (TFPB) is a recently described regional technique. In this study, we aimed to adapt this block into a laparoscopy-assisted approach and compare its analgesic efficacy with conventional wound infiltration in pediatric appendectomy.

METHODS: In this prospective, randomized controlled trial, 60 pediatric patients undergoing laparoscopic appendectomy were allocated to receive either laparoscopy-assisted TFPB (n = 30) or standard wound infiltration (WI; n = 30) with 0.25% bupivacaine (0.5 mL/kg). The primary outcome was postoperative pain evaluated via the FLACC (Face, Legs, Activity, Cry, Consolability) scale at seven time points within 24 h. Secondary outcomes included paracetamol consumption and parental satisfaction.

RESULTS: Demographic and perioperative variables were comparable between groups (p > 0.05). Paracetamol was required in significantly fewer patients in the TFPB group (36.7% vs 66.7%, p = 0.038), with fewer requiring repeated doses (13.3% vs 46.7%, p = 0.041). Although FLACC pain scores were statistically comparable between groups (p > 0.05), the TFPB group consistently showed lower median values from the fourth postoperative hour onward. Likewise, parental satisfaction was consistently high in both cohorts, with no significant variation between the analgesic techniques (p = 0.788). No adverse effects or block-related complications were reported.

CONCLUSION: Laparoscopy-assisted TFPB significantly reduced postoperative analgesic requirements compared to wound infiltration. Given its feasibility, efficacy, and safety, laparoscopy-assisted TFPB technique should be considered an alternative component of multimodal analgesia in pediatric laparoscopic abdominal surgery.

PMID:40971123 | DOI:10.1007/s11845-025-04088-y

Categories
Nevin Manimala Statistics

Short-term mTOR inhibition by rapamycin improves cardiac and endothelial function in older men: a proof-of concept pilot study

Geroscience. 2025 Sep 19. doi: 10.1007/s11357-025-01855-8. Online ahead of print.

ABSTRACT

Rapamycin (RAPA) and related mTOR-inhibitors have been shown to enhance healthy aging in animal models (2-10) and to be generally safe and tolerable in older people (11-13). However, studies to assess their effects on specific age-related pathologies in humans are limited. Since improvements in cardiovascular function with RAPA treatment have been reported in preclinical studies (5, 9, 10, 14-17), we posited that RAPA could be similarly efficacious in humans. Towards this end, we performed a pilot “proof of concept” trial to examine RAPA’s effects on cardiovascular and endothelial functions that are known to decline with age (18, 19). We hypothesized that RAPA would elicit beneficial cardiovascular effects in men. A cohort of older male subjects with no known cardiac disease (ages 70-76 years) were enrolled in the open-label study and received 1 mg RAPA/day for 8 weeks. To assess cardiovascular function, cardiac MRI (CMR) was performed twice: prior to initiation of the intervention and again after 8 weeks of treatment. Endothelial function was examined using laser-Doppler flowmetry (LDF) by measuring cutaneous, endothelium-dependent, local thermal hyperemic responses pre-intervention and after 4 and 8 weeks of RAPA (1). In all 6 subjects, transmitral blood flow, peak flow rate, and maximal blood acceleration showed statistically significant improvements while endothelial function also improved over the 8-week course of RAPA treatment. Thus, cardiac and endothelial function improvements with RAPA were found and support future placebo-controlled studies in larger cohorts of healthy older persons as well as in patients with compromised diastolic and endothelial function (20, 21).

PMID:40971115 | DOI:10.1007/s11357-025-01855-8

Categories
Nevin Manimala Statistics

Non-surgical periodontal treatment effects on IL-17 and IL-35 levels in smokers and non-smokers with periodontitis

Odontology. 2025 Sep 19. doi: 10.1007/s10266-025-01207-0. Online ahead of print.

ABSTRACT

Periodontitis, a chronic inflammatory disease influenced by host-microbiota interactions, poses a significant global health burden. Smoking exacerbates periodontitis progression and impacts treatment outcomes. Interleukin (IL)-17 and IL-35 are key mediators of inflammation, yet their roles in smoking-related periodontitis and responses to non-surgical periodontal treatment (NSPT) remain underexplored. This clinical trial aimed to evaluate the effects of NSPT on salivary and gingival crevicular fluid (GCF) levels of IL-17 and IL-35 in smokers and non-smokers with periodontitis. A total of 55 subjects were divided into three groups: smokers with periodontitis (SP), non-smokers with periodontitis (NSP), and healthy controls (C). All subjects underwent comprehensive periodontal assessments and cytokine level analyses at baseline and four weeks post-NSPT. Saliva and GCF samples were analysed for IL-17 and IL-35 using enzyme-linked immunosorbent assay (ELISA). Statistical analyses evaluated group differences and correlations. After NSPT, both SP and NSP groups exhibited significant improvements in clinical parameters (p < 0.05). Salivary IL-17 and IL-35 levels did not show significant differences between the SP, NSP, and C groups after NSPT (p > 0.05). However, in GCF, IL-17 and IL-35 concentrations significantly increased in both SP and NSP groups following NSPT (p < 0.05). The total amount of GCF IL-17 decreased significantly only in the NSP group after NSPT (p < 0.05), while the total amount of GCF IL-35 increased significantly in both SP and NSP groups (p < 0.05). Strong correlations between IL-17 and IL-35 levels in both saliva and GCF were observed. NSPT modulates inflammatory and anti-inflammatory cytokine profiles, promoting improved clinical outcomes. The impact of smoking on cytokine responses highlights the need for further research to elucidate the mechanisms underlying these cytokine modulations and their role in periodontal therapy. Trial registration ClinicalTrials.gov ( https://clinicaltrials.gov -01.01.2018-NCT05281848).

PMID:40971113 | DOI:10.1007/s10266-025-01207-0

Categories
Nevin Manimala Statistics

Using injectable Platelet-Rich fibrin to improve recovery after impacted lower third molar extraction: a randomized controlled clinical trial

Clin Oral Investig. 2025 Sep 19;29(10):467. doi: 10.1007/s00784-025-06563-3.

ABSTRACT

OBJECTIVES: The aim of this RCT was to clinically evaluate swelling, pain and wound healing following submucosal infiltration of injectable Platelet-Rich Fibrin (i-PRF) after extraction of impacted lower third molar.

MATERIALS AND METHODS: The study was designed as a double-blinded, parallel group, randomized controlled clinical trial. 56 patients were divided into 2 groups: in the control group the socket was left to heal spontaneously, while the test group was treated with submucosal infiltration of i-PRF. Swelling was measured with a flexible ruler using the diagonals joining Trago and Pogonion, Gonion and labial cleft. The swelling was calculated as the sum of these diagonals before surgery, on day 3 and 7. Pain was assessed by VAS scale until the 7th postoperative day. Surgical wound healing was evaluated by the Healing Index by Landry on 3, 7 ,14 and 21st day postosperatively. The relation between duration of intervention and total swelling was also evaluated.

RESULTS: 56 patients were enrolled in this study (28 for the test group and 28 for the control group). Randomization resulted in groups with similar baseline characteristics. No patients were lost during the follow-up and no adverse events were noted. On day 3 the total swelling was 12.7 ± 0.92 mm for control group and 12.1 ± 0.75 mm for test group; on day 7 it was 12.3 ± 0.88 mm for control group and 11.7 ± 0.73 mm for test group. A statistically significant difference was found on day 3 (p = 0.006) and on day 7 (p = 0.018). The relation between total swelling and duration of intervention was not statistically significant (p = 0.276). A significant reduction in pain scores was observed in the i-PRF group on days 1 and 3 (p < 0.001). Surgical wound healing also showed statistically significant improvement in the i-PRF group at all time points (days 3, 7, 14, and 21; p < 0.05).

CONCLUSIONS: Within the limit of our study, this randomized controlled clinical trial suggests that submucosal infiltration of i-PRF after the extraction of impacted lower third molars effectively reduces postoperative swelling and pain, while also promoting faster wound healing.

CLINICAL RELEVANCE: The adjunctive use of injectable platelet-rich fibrin (i‑PRF) after surgical removal of impacted mandibular third molars may contribute to improve early postoperative outcomes by attenuating soft tissue inflammation, reducing pain intensity, and accelerating wound healing. By potentially lowering the need for nonsteroidal anti-inflammatory drugs (NSAIDs) and minimizing associated adverse effects, i‑PRF represents a minimally invasive, autologous approach that could enhance patient comfort, reduce recovery time, and support faster return to daily activities.

PMID:40971054 | DOI:10.1007/s00784-025-06563-3

Categories
Nevin Manimala Statistics

Social Network Analysis of Secure Text Messaging Metadata During Clinical Deterioration in an Inpatient Children’s Hospital Setting

J Med Syst. 2025 Sep 19;49(1):116. doi: 10.1007/s10916-025-02250-8.

ABSTRACT

Mitigating clinical deterioration relies upon recognition (afferent limb) and interventions (efferent limb) by a healthcare team. Healthcare provider (HP) communication by text messaging plays a role in facilitating both limbs in the inpatient setting. We sought to quantitatively characterize healthcare provider team communications through the social network analysis (SNA) of secure text messages exchanged in the inpatient setting, and as they relate to a subgroup of patients demonstrating a deterioration during their hospitalization. Messages linked to inpatients exchanged between HPs over a 12-month period, including a cohort of messages linked to patients experiencing deterioration were analyzed using SNA. Subnetworks corresponding to individual patient encounters were constructed, including a series of subnetworks pertaining to patients with an impending clinical deterioration. Network and network participant characteristics were calculated and analyzed. From October 2022 through September 2023 there were 1,065,225 messages delivered by 3,272 HPs, associated with 4,328 inpatient hospital encounters, of which 120 hospital encounters were associated with a deterioration. SNA demonstrated significantly higher measures of eigenvector centrality among frontline providers (FLP) including advanced practice providers and housestaff, relative to attending physician (p < 0.001) and registered nurses (p < 0.001), consistent with greater influence of the FLP on information dissemination through the entire network. Within individual subnetworks associated with the care of patients experiencing a clinical deterioration, FLP participants demonstrated greater overall network influence (p = 0.032) relative to FLP counterparts in networks not associated with a deterioration, despite comparable numbers of participants and connections. Using SNA, we quantitatively characterized a text messaging network within an inpatient hospital setting, demonstrating the importance of FLPs on information dissemination, a finding demonstrated specifically within subnetworks dedicated to the care of individual deteriorating patients. Understanding characteristics of a dynamic communication network of healthcare providers may prove a valuable target in facilitating communication and in mitigating the risks of deterioration.IRB Approval: Johns Hopkins Medicine IRB (#CIR00419339).Clinical trial number: Not applicable.

PMID:40971050 | DOI:10.1007/s10916-025-02250-8

Categories
Nevin Manimala Statistics

Defining Low Muscle Mass in Cancer Patients: Sex-Specific Computed Tomography-Derived Cutoff Values and Survival Impact-A Multicenter Cohort Study

Ann Surg Oncol. 2025 Sep 19. doi: 10.1245/s10434-025-18264-y. Online ahead of print.

ABSTRACT

BACKGROUND: Low skeletal muscle mass is associated with adverse cancer outcomes and is a key diagnostic criterion for malnutrition in the Global Leadership Initiative on Malnutrition, emphasizing the importance of muscle mass assessment. This study aimed to establish sex-specific cutoff values for skeletal/psoas muscle mass index (SMI/PMI), calculated from computed tomography, in cancer patients for predicting prognosis.

METHODS: In this multicenter cohort study, preoperative SMI and PMI were analyzed in patients with gastric cancer who underwent gastrectomy without preoperative therapy between 2011 and 2016. Using 80% of the cases as a training set, sex-specific cutoffs for overall survival (OS) were determined via the optimal stratification method, adjusted for age and stage. The remaining 20% were used to validate OS differences between high and low muscle-mass groups.

RESULTS: Of 3841 registered patients from 17 hospitals, 3797 were analyzed. Spline plots showed a strong association between lower muscle mass and worse OS in males, but a weaker association in females. The SMI cutoffs were 40 cm2/m2 (males) and 31 cm2/m2 (females); PMI cutoffs were 3.7 cm2/m2 (males) and 2.9 cm2/m2 (females). In the validation set, low SMI and PMI were significantly associated with poor OS in males. In females, only PMI remained significant; body mass index better stratified prognosis than muscle indices.

CONCLUSIONS: The proposed cutoffs may facilitate the early identification of muscle loss or malnutrition, supporting timely intervention. The observed sex differences highlight the necessity to develop sex-specific strategies for nutritional and muscle mass management during cancer treatment.

PMID:40971041 | DOI:10.1245/s10434-025-18264-y

Categories
Nevin Manimala Statistics

Constructing and Validating the Spiritual Justice Scale: A Psychometric Study

J Relig Health. 2025 Sep 19. doi: 10.1007/s10943-025-02454-9. Online ahead of print.

ABSTRACT

The objective of this study was to develop and validate the Spiritual Justice Scale (SJS) as a reliable measure of individuals’ perceptions of spiritual justice. The development of the scale was founded upon theoretical foundations and supported by rigorous statistical analyses. Exploratory factor analysis revealed a one-dimensional structure explaining 56.26% of the variance, while confirmatory factor analysis confirmed the model with acceptable fit indices. Reliability analysis demonstrated high internal consistency (Cronbach’s α = 0.95). Furthermore, a significant positive correlation was identified between the SJS and the Toronto Empathy Questionnaire (r = 0.42, p < 0.001), suggesting a close relationship between spiritual justice and compassion, as well as fairness. The findings suggest that the SJS is a psychometrically sound instrument. Its potential applications extend to research and practice in counselling, education, social work, and spirituality studies, offering a foundation for further investigations into the role of spiritual justice in psychological well-being and social functioning.

PMID:40971019 | DOI:10.1007/s10943-025-02454-9